Expert Panel Consensus Statements on Vaccination for Adults with AIRD in India

• Published in: Indian journal of rheumatology
• Main Authors: Jain, Vikramraj, Mohanasundaram, Kavitha, Kumar, Sharath, Kavadichanda, Chengappa, Varaprasad, Rajendra, Mishra, Neha, Veeraraghavan, Balaji, Swaminathan, Subramanian, Lakshminarayanan, Devaki, Baghel, Sadhana, Shivashankar, Roopa, Ravindran, Vinod, Dharmanand, BG
• Format: Journal Article
• Language: English
• Published: 04.09.2024
• ISSN: 0973-3698; 0973-3701
• DOI: 10.1177/09733698241272078

Introduction: Due to notable distinctions in infection patterns, vaccine accessibility, and approaches to treatment among patients with autoimmune inflammatory rheumatic diseases (AIRD) in India compared to other regions globally, the Indian Rheumatology Association Vaccine (IRAVAC) group was formed to develop expert panel consensus statements on vaccination for adults with AIRDs in India. Methods: The IRAVAC group comprised seven rheumatologists, one epidemiologist, two infectious disease specialists, one clinical virologist, one specialist nurse, and a patient representative. The group determined the scope of the consensus statements, framed the research questions, and assigned a team of few members to review the evidence who designed the search strategy and conducted the systematic literature search and data extraction. Another group of members subsequently reviewed the articles for each vaccine, prepared a summary, generated draft statements, and assigned them an appropriate level of evidence. Eighty-eight such draft statements were circulated to the members of IRAVAC for review and deliberation. The draft statements were revised accordingly, and the final set of 48 statements on vaccinations for eight diseases was voted upon by the IRAVAC group, with a predefined 75% agreement set as a threshold for acceptance. It is envisaged that these consensus statements related to vaccination in AIRD would be helpful not only to rheumatologists in India but also to those in other countries.